Literature DB >> 10837491

Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation.

K Kimura1, T Tsuji, Y Takada, T Miki, S Narumiya.   

Abstract

We developed a new pull-down assay for GTP-Rho and examined its level during cell cycle. HeLa cells were arrested in the S phase by thymidine and were enriched in the prometaphase, metaphase, telophase, and G(1) phase by collecting at 0, 45, 90, and 180 min after the release from the nocodazole arrest, respectively. The level of GTP-Rho did not change significantly from the S phase to the prometaphase, but increased thereafter, peaking in the telophase, and returned to the original level in the G(1) phase. The GDP-GTP exchange activity for Rho measured in cell lysates in parallel increased also during the mitosis with a peak in the metaphase. Using this system, we examined a role of ECT2, an exchanger for Rho GTPases, suggested to be involved in cytokinesis (Tatsumoto, T., Xie, X., Blumenthal, R., Okamoto, I., and Miki., T. (1999) J. Cell. Biol. , 147, 921-928). Expression of the dominant negative form of ECT2 completely suppressed both the rise of GTP-Rho in the telophase and the increased GDP-GTP exchange activity in the mitotic cell extracts. These results suggest a critical role of ECT2 in Rho activation during cytokinesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837491     DOI: 10.1074/jbc.C000212200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis.

Authors:  Sergio A Sánchez Manchinelly; Joyce Agati Miller; Ling Su; Tsuyoshi Miyake; Lisa Palmer; Masahito Mikawa; Sarah J Parsons
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest.

Authors:  Neil A Bhowmick; Mayshan Ghiassi; Mary Aakre; Kimberly Brown; Vikas Singh; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Nir2, a human homolog of Drosophila melanogaster retinal degeneration B protein, is essential for cytokinesis.

Authors:  Vladimir Litvak; Donguha Tian; Shari Carmon; Sima Lev
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

4.  The actin-bundling protein cortexillin is the downstream target of a Rac1-signaling pathway required for cytokinesis.

Authors:  J Faix
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

5.  Nucleotide exchange factor ECT2 interacts with the polarity protein complex Par6/Par3/protein kinase Czeta (PKCzeta) and regulates PKCzeta activity.

Authors:  Xiu-Fen Liu; Hiroshi Ishida; Razi Raziuddin; Toru Miki
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  PAS kinase promotes cell survival and growth through activation of Rho1.

Authors:  Caleb M Cardon; Thomas Beck; Michael N Hall; Jared Rutter
Journal:  Sci Signal       Date:  2012-01-31       Impact factor: 8.192

7.  MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis.

Authors:  Wei-meng Zhao; Guowei Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

8.  Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle.

Authors:  Disha Dadke; Michael Jarnik; Elena N Pugacheva; Mahendra K Singh; Erica A Golemis
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

9.  Genetic evidence for antagonism between Pak protein kinase and Rho1 small GTPase signaling in regulation of the actin cytoskeleton during Drosophila oogenesis.

Authors:  Stephanie Vlachos; Nicholas Harden
Journal:  Genetics       Date:  2010-11-23       Impact factor: 4.562

Review 10.  Molecular Mechanism of Cytokinesis.

Authors:  Thomas D Pollard; Ben O'Shaughnessy
Journal:  Annu Rev Biochem       Date:  2019-01-16       Impact factor: 23.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.